The impact of physical activity on promoter-specific methylation of genes involved in the redox-status and disease progression : A longitudinal study on post-surgery female breast cancer patients undergoing medical treatment
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved..
Most anticancer treatments act on oxidative-stress pathways by producing reactive oxygen species (ROS) to kill cancer cells, commonly resulting in consequential drug-induced systemic cytotoxicity. Physical activity (PA) has arisen as an integrative cancer therapy, having positive health effects, including in redox-homeostasis. Here, we investigated the impact of an online supervised PA program on promoter-specific DNA methylation, and corresponding gene expression/activity, in 3 antioxidants- (SOD1, SOD2, and CAT) and 3 breast cancer (BC)-related genes (BRCA1, L3MBTL1 and RASSF1A) in a population-based sample of women diagnosed with primary BC, undergoing medical treatment. We further examined mechanisms involved in methylating and demethylating pathways, predicted biological pathways and interactions of exercise-modulated molecules, and the functional relevance of modulated antioxidant markers on parameters related to aerobic capacity/endurance, physical fatigue and quality of life (QoL). PA maintained levels of SOD activity in blood plasma, and at the cellular level significantly increased SOD2 mRNA (≈+77 %), contrary to their depletion due to medical treatment. This change was inversely correlated with DNA methylation in SOD2 promoter (≈-20 %). Similarly, we found a significant effect of PA only on L3MBTL1 promoter methylation (≈-25 %), which was inversely correlated with its mRNA (≈+43 %). Finally, PA increased TET1 mRNA levels (≈+15 %) and decreased expression of DNMT3B mRNA (≈-28 %). Our results suggest that PA-modulated DNA methylation affects several signalling pathways/biological activities involved in the cellular oxidative stress response, chromatin organization/regulation, antioxidant activity and DNA/protein binding. These changes may positively impact clinical outcomes and improve the response to cancer treatment in post-surgery BC patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:70 |
---|---|
Enthalten in: |
Redox biology - 70(2024) vom: 21. Feb., Seite 103033 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Moulton, Chantalle [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antioxidants |
---|
Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.redox.2024.103033 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367019892 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367019892 | ||
003 | DE-627 | ||
005 | 20240229154848.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.redox.2024.103033 |2 doi | |
028 | 5 | 2 | |a pubmed24n1306.xml |
035 | |a (DE-627)NLM367019892 | ||
035 | |a (NLM)38211440 | ||
035 | |a (PII)S2213-2317(24)00009-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Moulton, Chantalle |e verfasserin |4 aut | |
245 | 1 | 4 | |a The impact of physical activity on promoter-specific methylation of genes involved in the redox-status and disease progression |b A longitudinal study on post-surgery female breast cancer patients undergoing medical treatment |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.02.2024 | ||
500 | |a Date Revised 26.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved. | ||
520 | |a Most anticancer treatments act on oxidative-stress pathways by producing reactive oxygen species (ROS) to kill cancer cells, commonly resulting in consequential drug-induced systemic cytotoxicity. Physical activity (PA) has arisen as an integrative cancer therapy, having positive health effects, including in redox-homeostasis. Here, we investigated the impact of an online supervised PA program on promoter-specific DNA methylation, and corresponding gene expression/activity, in 3 antioxidants- (SOD1, SOD2, and CAT) and 3 breast cancer (BC)-related genes (BRCA1, L3MBTL1 and RASSF1A) in a population-based sample of women diagnosed with primary BC, undergoing medical treatment. We further examined mechanisms involved in methylating and demethylating pathways, predicted biological pathways and interactions of exercise-modulated molecules, and the functional relevance of modulated antioxidant markers on parameters related to aerobic capacity/endurance, physical fatigue and quality of life (QoL). PA maintained levels of SOD activity in blood plasma, and at the cellular level significantly increased SOD2 mRNA (≈+77 %), contrary to their depletion due to medical treatment. This change was inversely correlated with DNA methylation in SOD2 promoter (≈-20 %). Similarly, we found a significant effect of PA only on L3MBTL1 promoter methylation (≈-25 %), which was inversely correlated with its mRNA (≈+43 %). Finally, PA increased TET1 mRNA levels (≈+15 %) and decreased expression of DNMT3B mRNA (≈-28 %). Our results suggest that PA-modulated DNA methylation affects several signalling pathways/biological activities involved in the cellular oxidative stress response, chromatin organization/regulation, antioxidant activity and DNA/protein binding. These changes may positively impact clinical outcomes and improve the response to cancer treatment in post-surgery BC patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Antioxidants | |
650 | 4 | |a Breast cancer | |
650 | 4 | |a DNA methylation | |
650 | 4 | |a Epigenetic | |
650 | 4 | |a Exercise | |
650 | 4 | |a Oxidative stress | |
650 | 4 | |a Redox-status | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a TET1 protein, human |2 NLM | |
650 | 7 | |a EC 1.- |2 NLM | |
650 | 7 | |a Mixed Function Oxygenases |2 NLM | |
650 | 7 | |a EC 1.- |2 NLM | |
650 | 7 | |a Proto-Oncogene Proteins |2 NLM | |
700 | 1 | |a Murri, Arianna |e verfasserin |4 aut | |
700 | 1 | |a Benotti, Gianmarco |e verfasserin |4 aut | |
700 | 1 | |a Fantini, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Duranti, Guglielmo |e verfasserin |4 aut | |
700 | 1 | |a Ceci, Roberta |e verfasserin |4 aut | |
700 | 1 | |a Grazioli, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Cerulli, Claudia |e verfasserin |4 aut | |
700 | 1 | |a Sgrò, Paolo |e verfasserin |4 aut | |
700 | 1 | |a Rossi, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Magno, Stefano |e verfasserin |4 aut | |
700 | 1 | |a Di Luigi, Luigi |e verfasserin |4 aut | |
700 | 1 | |a Caporossi, Daniela |e verfasserin |4 aut | |
700 | 1 | |a Parisi, Attilio |e verfasserin |4 aut | |
700 | 1 | |a Dimauro, Ivan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Redox biology |d 2013 |g 70(2024) vom: 21. Feb., Seite 103033 |w (DE-627)NLM22743725X |x 2213-2317 |7 nnns |
773 | 1 | 8 | |g volume:70 |g year:2024 |g day:21 |g month:02 |g pages:103033 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.redox.2024.103033 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 70 |j 2024 |b 21 |c 02 |h 103033 |